Ekso Bionics Holdings, Inc. lost $4.91 per diluted share in fiscal year 2025. The table below carries 14 fiscal years, from 2012 to 2025, and the quarters Ekso Bionics Holdings, Inc. has filed alongside them.
FY2025 annual
EPS (Diluted)-$4.91
Ticker history: EKSO became
CHRN
(ChronoScale Holdings Corporation) on .
Earlier news and filings retain their original names and dates.
View EKSO history.
Source SEC Filings (10-K/10-Q)Latest period Q1 FY2026, ended Mar 31, 2026ReportedCurrency USD
Annual figures, oldest first. Point at a bar to read its period.
EKSO EPS (Diluted) by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
Ekso Bionics Holdings, Inc. lost $4.91 per diluted share in fiscal year 2025.
Ekso Bionics Holdings, Inc. (EKSO) reported -$2.04 in diluted earnings per share in Q1 2026.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Ekso Bionics Holdings, Inc. (EKSO) reported on that line in every period on record.
